I am a computational biologist specializing in AI-driven target identification and bioinformatics for drug discovery. As a Senior Scientist at Sygnature Discovery, I design and implement workflows that integrate semi-automated annotation with expert review to accelerate target evaluation and prioritization. My work bridges data science and experimental biology, enabling the identification of discovery-ready targets for diverse therapeutic areas. Previously, I was in academia for more than a decade contributing to antimicrobial resistance research . My goal is to advance innovative strategies for target ID that combine AI, informatics, and multidisciplinary insights to improve translational success